Ivan Namakoola
Biographic Data
| ID | 6777466 |
|---|---|
| NAME | Ivan Namakoola |
| GIVEN NAMES | Ivan |
| FAMILY NAME | Namakoola |
| SIGNATURE | NAMAKOOLA I |
| AFFILIATIONS | Uganda Virus Research Institute |
| ORCID | 0000-0002-4980-1998 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Estimated cost-savings from integrated care for HIV, diabetes and hypertension in sub-Saharan Africa
Background In a cluster-randomised trial in Uganda and Tanzania, we showed that integrated management, compared with standard vertical care, could achieve a high standard of care for diabetes and hypertension without adversely affecting outcomes for HIV. However, evidence on the value for money of integrated care is needed to inform policy.Objective Our economic evaluation aimed to establish the value for money of integrated care compared with ve…
Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa
Evidence on the benefits of integrated care remains limited. More robust evidence will be essential to guide scale-up beyond research sites
Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan Africa
Conducting intervention studies in Africa, where medicines supply for chronic conditions is inequitable and patchy, raises major ethical issues. \n \nHere we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension
Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa
Evidence on the benefits of integrated care remains limited. More robust evidence will be essential to guide scale-up beyond research sites
Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan Africa
Conducting intervention studies in Africa, where medicines supply for chronic conditions is inequitable and patchy, raises major ethical issues. \n \nHere we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension
Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa
Evidence on the benefits of integrated care remains limited. More robust evidence will be essential to guide scale-up beyond research sites
Estimated cost-savings from integrated care for HIV, diabetes and hypertension in sub-Saharan Africa
Background In a cluster-randomised trial in Uganda and Tanzania, we showed that integrated management, compared with standard vertical care, could achieve a high standard of care for diabetes and hypertension without adversely affecting outcomes for HIV. However, evidence on the value for money of integrated care is needed to inform policy.Objective Our economic evaluation aimed to establish the value for money of integrated care compared with ve…
Health care (3 works) · HIV/AIDS Research and Interventions (3 works) · Chronic care (2 works) · Chronic disease (2 works) · Diabetes mellitus (2 works) · Economic growth (2 works) · Family medicine (2 works) · HIV-related health complications and treatments (2 works) · Integrated care (2 works) · Medicine (2 works)